These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 18403070

  • 1. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH, De Vusser K, Laroy W, Daurelio L, Nocito AL, Revelli S, Contreras R.
    Vaccine; 2008 May 02; 26(19):2322-34. PubMed ID: 18403070
    [Abstract] [Full Text] [Related]

  • 2. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.
    Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of the recombinant SAPA protein of Trypanosoma cruzi for mice.
    Nasser JR, Gómez LE, Sánchez D, Guerin M, Basombrío MA.
    J Parasitol; 1997 Feb 03; 83(1):76-81. PubMed ID: 9057700
    [Abstract] [Full Text] [Related]

  • 5. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H.
    Vaccine; 2009 Oct 19; 27(44):6154-9. PubMed ID: 19712768
    [Abstract] [Full Text] [Related]

  • 6. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ, Wrightsman RA, Manning JE.
    Exp Parasitol; 1996 Nov 19; 84(2):156-67. PubMed ID: 8932765
    [Abstract] [Full Text] [Related]

  • 7. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, Bruña-Romero O, Alvarez JM, Boscardin SB, Rodrigues MM.
    Hum Gene Ther; 2004 Sep 19; 15(9):878-86. PubMed ID: 15353042
    [Abstract] [Full Text] [Related]

  • 8. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B, Cervetta L, Moretti E, Carlier Y, Truyens C.
    Vaccine; 2004 May 07; 22(15-16):1868-72. PubMed ID: 15121297
    [Abstract] [Full Text] [Related]

  • 9. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG, Pitcovsky TA, Caccuri RL, Campetella O, Leguizamón MS.
    Parasitology; 2007 Apr 07; 134(Pt 4):503-10. PubMed ID: 17166319
    [Abstract] [Full Text] [Related]

  • 10. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
    Bontempi I, Fleitas P, Poato A, Vicco M, Rodeles L, Prochetto E, Cabrera G, Beluzzo B, Arias D, Racca A, Guerrero S, Marcipar I.
    Immunotherapy; 2017 Jun 07; 9(7):555-565. PubMed ID: 28595515
    [Abstract] [Full Text] [Related]

  • 11. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N, Tarleton RL.
    Infect Immun; 2002 Oct 07; 70(10):5547-55. PubMed ID: 12228281
    [Abstract] [Full Text] [Related]

  • 12. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
    Pereira-Chioccola VL, Costa F, Ribeirão M, Soares IS, Arena F, Schenkman S, Rodrigues MM.
    Parasite Immunol; 1999 Feb 07; 21(2):103-10. PubMed ID: 10101720
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS, Zhang X, Vasconcelos JR, Motz RG, Sullivan NL, O'Shea K, Pozzi N, Gohara DW, Blase JR, Di Cera E, Hoft DF.
    PLoS Pathog; 2016 Sep 07; 12(9):e1005896. PubMed ID: 27642757
    [Abstract] [Full Text] [Related]

  • 17. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF, Eickhoff CS, Giddings OK, Vasconcelos JR, Rodrigues MM.
    J Immunol; 2007 Nov 15; 179(10):6889-900. PubMed ID: 17982080
    [Abstract] [Full Text] [Related]

  • 18. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN, Castelo-Branco MT, Lannes-Vieira J, Gattass CR.
    Exp Parasitol; 1999 Jan 15; 91(1):7-19. PubMed ID: 9920038
    [Abstract] [Full Text] [Related]

  • 19. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Sánchez-Burgos G, Ramirez-Sierra MJ, Cruz-Chan JV, VanWynsberghe NR, Dumonteil E.
    Vaccine; 2010 Oct 28; 28(46):7414-9. PubMed ID: 20850536
    [Abstract] [Full Text] [Related]

  • 20. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F, Franchin G, Pereira-Chioccola VL, Ribeirão M, Schenkman S, Rodrigues MM.
    Vaccine; 1998 May 28; 16(8):768-74. PubMed ID: 9627933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.